Sequins™ Launches Innovative Products to Transform Sequencing Assays and Meet Market Demands

Sequins™ Launches Innovative Products



Recently, Sequins, an emerging start-up within the next-generation sequencing (NGS) realm, proudly announced the launch of its first commercial products. This pivotal move marks the introduction of the Sequins Metagenomics Core Control and Whole Genome Sequencing Core Control Sets. Furthermore, they have unveiled an evaluation program for circulating tumor DNA (ctDNA) Controls—essential tools for enhancing the precision of genomic studies.

These newly available products establish a groundbreaking standard for workflow monitoring and optimization. They act as internal spike-in controls, facilitating uniformity across samples, equipment, operators, and laboratories alike. The Sequins can be specifically manufactured with molecular ladders, providing quantitative measures that are critical for normalization during sequencing.

In essence, Sequins consists of synthetic nucleic acid controls designed to mirror naturally occurring sequences. The technology ensures that Sequins maintain identical nucleotide compositions compared to natural sequences, allowing an accurate representation of genomic complexity without affecting the integrity of the samples or the final results.

Product Highlights



1. Sequins Metagenomics Core Control Set: This product offers unprecedented capabilities for normalization and quantification of microbes in complex environmental samples, encompassing over 50 microbial species at various abundance levels.

2. Sequins Whole Genome Sequencing (WGS) Core Control Set: This innovative kit sets a new benchmark for workflow monitoring and includes difficult class genetic variants, homopolymers, and mitochondrial DNA, thereby supporting a wide range of analysis.

3. Sequins ctDNA Evaluation Set: Specifically designed for workflow monitoring and for quantifying ctDNA, this set covers nine critical cancer genes at varied allele frequencies, allowing researchers to calibrate their assays effectively.

Alex Gough, CEO and Co-Founder of Sequins, expressed his excitement about the launch, stating that the technology represents a significant advancement in refining sequencing assays. He highlighted the company’s commitment to quality, emphasizing the extensive investments made in production and quality control to empower researchers utilizing Sequins for their essential projects.

Additionally, Sequins recently made a significant staffing decision by onboarding Jeremy Preston as Senior Vice President. Preston comes with over 20 years of expansive experience within the genomics industry, having held vital roles at notable organizations like Affymetrix and Illumina. His expertise is expected to play a crucial role in scaling Sequins’ operational capabilities and customer success efforts.

Jeremy Preston remarked on his excitement about joining the Sequins team, emphasizing that he sees great potential for Sequins technology to become an integral part of sequencing assays across the industry. He noted how the capability to provide on-demand products tailored to the dynamic nature of the genomics sector will assist in advancing best practices within the community.

About Sequins



Sequins is a privately owned genomics technology firm based in San Francisco, USA, and Sydney, Australia. Founded from a successful research program at the Garvan Institute in Sydney, the company has made significant strides in developing innovative DNA and RNA sequencing control standards. Their technology ensures that controls can be introduced into individual samples without jeopardizing their integrity, paving the way for various applications in genomics research.

For further details and updates on Sequins’ products, resource materials, and developments, please visit www.sequins.bio and follow them on Bluesky and LinkedIn.

Topics Consumer Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.